11 – 12 May 2017 | New York, NY

Register

AGENDA

Thursday 11 May 2017

8:00 AM – 9:00 AM 8:00 AM – 9:00 AM

Buffet Breakfast

Palm & Terrace, Lobby Level
Palm & Terrace, Lobby Level
8:00 AM – 9:00 AM 8:00 AM – 9:00 AM

CME Sign-In / Registration

Elevator Lobby, Mezzanine Level
Elevator Lobby, Mezzanine Level
9:00 AM – 11:30 AM 9:00 AM – 11:30 AM

AM Plenary Session

Grand Ballroom, Mezzanine Level
Grand Ballroom, Mezzanine Level

Opening Remarks

Robert Klein, MD, Carol Harris, MD, MSc
Robert Klein, MD, Carol Harris, MD, MSc

Immune Based Therapies

Peter Hunt, MD
Peter Hunt, MD

Antiretroviral Therapy Progress

Roy Gulick, MD, MPH
Roy Gulick, MD, MPH

Antiretroviral Therapy: What to Start & When to Switch

Joel Gallant, MD, MPH
Joel Gallant, MD, MPH

Update on Biomedical Prevention

Thomas Quinn, MD, MSc
Thomas Quinn, MD, MSc

Panel Q&A

Moderator: Carol Harris, MD, MSc
Panel: Peter Hunt, MD; Roy Gulick, MD, MPH;
Joel Gallant, MD, MPH; Thomas Quinn, MD, MSc
Moderator: Carol Harris, MD, MSc
Panel: Peter Hunt, MD; Roy Gulick, MD, MPH;
Joel Gallant, MD, MPH; Thomas Quinn, MD, MSc
11:30 AM – 11:50 AM 11:30 AM – 11:50 AM

Transition to Lunch Breakout Sessions

11:50 AM – 12:50 PM 11:50 AM – 12:50 PM

Concurrent Case-Based Breakout Sessions

Locations Posted
Locations Posted

•  Antiretroviral Therapy: Switching Strategies

Joel Gallant, MD, MPH; Roy Gulick, MD, MPH

•  HIV Drug Interactions and Toxicities

David Back, PhD; David Thomas, MD, MPH

•  Managing HIV/Hepatitis Coinfection

Marion Peters, MD

•  Treating Hepatitis C in Special Populations

Mark Sulkowski, MD
Joel Gallant, MD, MPH; Roy Gulick, MD, MPH
David Back, PhD; David Thomas, MD, MPH
Marion Peters, MD
Mark Sulkowski, MD
12:50 PM – 1:00 PM 12:50 PM – 1:00 PM

Transition to Plenary Session

1:00 PM – 5:00 PM 1:00 PM – 5:00 PM

PM Plenary Session

Grand Ballroom, Mezzanine Level
Grand Ballroom, Mezzanine Level

AIDS-defining Cancers: What’s New with the Old?

Alexandra Levine, MD, MACP
Alexandra Levine, MD, MACP

STI Update: Screening, Treatment and Resistance

Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH

Beyond MI: Cardiovascular Disease in
the ART-Treated Patient

Christopher Longenecker, MD
Christopher Longenecker, MD

Coffee Break

Diabetes Mellitus Risk Assessment and
Treatment Considerations

Todd Brown, MD, PhD
Todd Brown, MD, PhD

HIV and Aging: Optimizing Neurocognitive Function

Scott Letendre, MD
Scott Letendre, MD

Panel Q&A

Moderator: Robert Klein, MD
Panel: Alexandra Levine, MD, MACP; Jeanne
Marrazzo, MD, MPH; Christopher Longenecker, MD;
Todd Brown MD, PhD; Scott Letendre, MD
Moderator: Robert Klein, MD
Panel: Alexandra Levine, MD, MACP; Jeanne
Marrazzo, MD, MPH; Christopher Longenecker, MD;
Todd Brown MD, PhD; Scott Letendre, MD

What Every HIV Clinician Needs to
Know About Infectious Diseases

John Bartlett, MD
John Bartlett, MD

Day 1 Closing Remarks

Robert Klein, MD
Robert Klein, MD
5:00 PM – 6:30 PM 5:00 PM – 6:30 PM

Cocktail Reception and Exhibits

Palm & Terrace, Lobby Level
Palm & Terrace, Lobby Level

Friday 12 May 2017

8:00 AM – 9:00 AM 8:00 AM – 9:00 AM

Buffet Breakfast

Palm & Terrace, Lobby Level
Palm & Terrace, Lobby Level
9:00 AM – 12:30 PM 9:00 AM – 12:30 PM

AM Plenary Session

Grand Ballroom, Mezzanine Level
Grand Ballroom, Mezzanine Level

Opening Remarks

John Reinus, MD
John Reinus, MD

The ABCs of Liver Disease

John Reinus, MD
John Reinus, MD

HBV Diagnosis and Treatment – State of the Art

Anna Lok, MD
Anna Lok, MD

HBV Treatment Pipeline: Prospects For a Cure

Marion Peters, MD
Marion Peters, MD

HBV Reactivation: A Preventable Menace

Raymond Chung, MD
Raymond Chung, MD

Panel Q&A

Moderator: David Thomas, MD, MPH
Panel: John Reinus, MD; Anna Lok, MD;
Marion Peters, MD; Raymond Chung, MD
Moderator: David Thomas, MD, MPH
Panel: John Reinus, MD; Anna Lok, MD;
Marion Peters, MD; Raymond Chung, MD

Coffee Break

Hepatitis C Therapies – State of the Art

Elizabeth Verna, MD, MS
Elizabeth Verna, MD, MS

Controversies in Hepatitis C Management

Michael Charlton, MD
Michael Charlton, MD

Panel Q&A

Moderator: David Thomas, MD, MPH
Panel: Elizabeth Verna, MD, MS;
Michael Charlton, MD
Moderator: David Thomas, MD, MPH
Panel: Elizabeth Verna, MD, MS;
Michael Charlton, MD
12:30 PM – 12:50 PM 12:30 PM – 12:50 PM

Transition to Lunch Breakout Sessions

12:50 PM – 1:50 PM 12:50 PM – 1:50 PM

Concurrent Case-Based Breakout Sessions

Locations Posted
Locations Posted

•  Antiretroviral Therapy: Switching Strategies

Joel Gallant, MD, MPH; Roy Gulick, MD, MPH

•  HIV Drug Interactions and Toxicities

David Back, PhD; David Thomas, MD, MPH

•  Managing HIV/Hepatitis Coinfection

Marion Peters, MD

•  Treating Hepatitis C in Special Populations

Mark Sulkowski, MD
Joel Gallant, MD, MPH; Roy Gulick, MD, MPH
David Back, PhD; David Thomas, MD, MPH
Marion Peters, MD
Mark Sulkowski, MD
1:50 PM – 2:00 PM 1:50 PM – 2:00 PM

Transition to Plenary Session

2:00 PM – 4:30 PM 2:00 PM – 4:30 PM

PM Plenary Session

Grand Ballroom, Mezzanine Level
Grand Ballroom, Mezzanine Level

Drug-Drug Interactions of HBV and HCV Regimens

David Back, PhD
David Back, PhD

Retreatment in the Face of DAA Resistance

David Wyles, MD
David Wyles, MD

Managing After the Cure: Hepatocellular
Carcinoma, Fatty Liver Disease and More

Robert Brown Jr, MD, MPH
Robert Brown Jr, MD, MPH

The Cost of NOT Treating HCV Infection:
What Clinicians Need to Know

David Thomas, MD, MPH
David Thomas, MD, MPH

Panel Q&A

Moderator: Raymond Chung, MD
Panel: David Back, PhD; David Wyles, MD;
Robert Brown Jr, MD, MPH; David Thomas, MD, MPH
Moderator: Raymond Chung, MD
Panel: David Back, PhD; David Wyles, MD;
Robert Brown Jr, MD, MPH; David Thomas, MD, MPH

Concluding Remarks

Raymond Chung, MD
Raymond Chung, MD
4:30 PM – 5:00 PM 4:30 PM – 5:00 PM

CME & CE Certificate Distribution

Elevator Lobby, Mezzanine Level
Elevator Lobby, Mezzanine Level